尽管目前全球仅有5000名婴幼儿使用该药，但罕见病药物的高定价模式，叠加长期持续给药的治疗需求，让Vosoritide的商业表现持续走高。2025年，该药销售额达9.27亿美元，同比增长26%，是BioMarin的核心商业化增长引擎。
a banked consumer, even the teller was mostly gone. Today, we get our cash from
，推荐阅读搜狗输入法2026获取更多信息
"I had anxiety and overwhelm, my stress levels were through the roof. I was having anger fits that I had no idea why," she said.
FT Videos & Podcasts